With the outbreak of the second peak of COVID-19 in many countries of the world, the
symptoms and complications of this disease has received a great deal of attention. One of …

Background and purpose An increasing number of reports have observed thrombosis in
severe cases of COVID-19. The aim of this study was to evaluate the incidence of …

Abstract Coronavirus disease 2019 (COVID-19) was initially recognized in late December
2019 and has quickly spread globally with over 114 million reported cases worldwide at the …

Introduction The acute disease caused by the severe acute respiratory syndrome
coronavirus 2 (SARS COV-2) is accompanied by a hypercoagulable state. Multiple …

There is some recent evidence that the coronavirus disease 2019 (COVID-19) increases the
risk of venous thromboembolism by creating a prothrombotic state. COVID-19 and …

Coronavirus disease 2019 (COVID-19) does not only affect the respiratory system but
appears to be a systemic disease. Venous thromboembolism is a common manifestation in …

The COVID-19 pandemic affects more than two million people to date with a high
prevalence of thromboembolic events (TEE) and disseminated intravascular coagulation …

Abstract The Coronavirus Disease 2019 (COVID 19) has been reported in almost every
country in the world. Although a large proportion of infected individuals develop only mild …

The symptomology of patients afflicted with novel 2019 coronavirus disease (SARS-CoV-2
or COVID-19) has varied greatly, ranging from the asymptomatic state to debilitating …

Background The ongoing global pandemic of coronavirus disease 2019 (COVID-19) may
cause, in addition to lung disease, a wide spectrum of non-respiratory complications. Among …